# Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS

> **NCT06109064** · PHASE2 · UNKNOWN · sponsor: **Anhui Provincial Hospital** · enrollment: 14 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** Unrelated Umbilical Cord Blood
- **DRUG:** Venetoclax
- **DRUG:** Decetabine
- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT06109064
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-27
- **Primary completion:** 2024-02-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06109064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06109064, "Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06109064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*